| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.37▲ | 7.34▲ | 7.30▲ | 7.07▲ | 7.98▼ |
| MA10 | 7.34▲ | 7.27▲ | 7.14▲ | 7.35▲ | 7.75▼ |
| MA20 | 7.32▲ | 7.11▲ | 7.00▲ | 7.87▼ | 7.69▼ |
| MA50 | 7.27▲ | 6.99▲ | 7.20▲ | 7.69▼ | 5.37▲ |
| MA100 | 7.15▲ | 7.27▲ | 7.47▼ | 7.73▼ | 4.31▲ |
| MA200 | 7.01▲ | 7.54▼ | 7.92▼ | 5.89▲ | 4.20▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | 0.032▲ | 0.077▲ | -0.105▼ | -0.203▼ |
| RSI | 79.109▲ | 73.593▲ | 67.537▲ | 47.206▼ | 52.382▲ |
| STOCH | 78.399 | 89.350▲ | 89.641▲ | 18.935▼ | 52.699 |
| WILL %R | -2.778▲ | -0.725▲ | -0.690▲ | -46.667 | -72.881 |
| CCI | 283.080▲ | 148.950▲ | 121.311▲ | -37.076 | -74.104 |
|
Thursday, July 30, 2026 07:15 AM
USA-based ImmunityBio has secured marketing authorization in the United Arab Emirates (UAE) for Anktiva (nogapendekin alfa inbakicept) across two cancer indications.
|
|
Thursday, July 30, 2026 06:43 AM
ImmunityBio (NASDAQ:IBRX) shares climbed 7.5% on Thursday after the company announced that the United Arab Emirates had granted marketing approval for ANKTIVA in two cancer indications, further ...
|
|
Thursday, July 30, 2026 02:35 AM
Data on Stocktwits showed that retail sentiment remains ‘bearish’ on SPY and QQQ.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/07/26 | 7.22 | 7.47 | 7.00 | 7.45 | 10,690,321 |
| 29/07/26 | 7.00 | 7.13 | 6.735 | 6.83 | 8,205,023 |
| 28/07/26 | 6.93 | 6.99 | 6.65 | 6.97 | 11,781,652 |
| 27/07/26 | 7.25 | 7.37 | 6.90 | 6.99 | 10,488,161 |
| 24/07/26 | 7.40 | 7.451 | 7.0637 | 7.10 | 8,495,538 |
| 23/07/26 | 7.36 | 7.57 | 7.34 | 7.40 | 6,073,285 |
| 22/07/26 | 7.98 | 8.10 | 7.495 | 7.51 | 8,633,167 |
| 21/07/26 | 7.57 | 8.14 | 7.54 | 8.07 | 8,564,301 |
| 20/07/26 | 7.65 | 7.781 | 7.43 | 7.495 | 7,203,588 |
| 17/07/26 | 7.27 | 7.79 | 7.26 | 7.68 | 9,010,151 |
|
|
||||
|
|
||||
|
|